Giving hope to breast cancer sufferers
The campaign is aimed at addressing the backlog in breast cancer surgeries in the country's public hospitals.
Despite their long schedules and call times, 15 volunteer doctors came together to provide seven women with much-needed mastectomy surgeries.
According to Michael Brombacher, the doctor leading the surgeries and the campaign, the project will drastically decrease the waiting time for patients needing operations.
'Before we started this project, patients were waiting a long time for surgeries,' he said.
'To get the diagnosis that you had breast cancer, and then be told you had to wait three months before you could start treatment, was a problem.
'Now we have been able to bring that waiting period down to an achievable time frame.
'You can see that sense of comfort on the patients' faces.
'The other aspect is the teamwork among the young doctors, and seeing them give their time and energy to help patients, and not be paid for it, that for me is huge.
'It also shows me that healthcare is in good hands.'
The campaign has been rolled out in Gqeberha, Cape Town, George, East London and Mdantsane.
It has brought together a group of volunteer surgeons, anaesthetists and nursing staff to assist women who have been stuck on waiting lists for breast cancer treatments.
Project Flamingo is a nonprofit and is committed to providing holistic support for women battling breast cancer in the public healthcare sector.
Since it started in 2010, the team has performed more than 1,800 breast cancer surgeries across the country.
The chief executive and founder of the organisation, Dr Liana Roodt, said it reflected the true spirit of Nelson Mandela.
'We are not just commemorating a rich history left by a remarkable man, we are changing lives.
'There is no greater way to honour a great leader than to proactively mirror his legacy of positive change.
'We are creating space for women to be heard, treated and to reclaim their health and dignity.
'Let's all 'make room for her' and for each other by the way we talk, think and act.
'Timely and dignified cancer care is not a privilege, it is a basic human right which should be protected and claimed.'
Angelita Davids, 48, was one of the patients to experience the positive impact of the campaign on her life.
After her diagnosis in May, she was added to the list of beneficiaries of the campaign.
She expressed how her life had already changed for the better.
'My mother had cancer, but I had no signs or symptoms,' she said.
'I just went for a routine check-up and they told me I must go for a mammogram.
'I had no money to do that, but they called me a few weeks later and told me I was part of this campaign.
'This is such an awesome programme.
'I was very scared about the surgery and coming here, but when I found out it would be a group of ladies who also have breast cancer, I relaxed because I knew I wouldn't be alone.
'I have made friends for life here.'
The Herald
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Herald
6 hours ago
- The Herald
Drowning rates in SA go up while global figures drop, says Lifesaving SA
Drownings in South Africa are increasing, bucking the global trend where the rates are dropping, Lifesaving South Africa (LSA) warned in a statement to mark World Drowning Prevention Day on Friday. 'While global drowning deaths have dropped by 38% over the past two decades, South Africa's rates are rising,' the federation said, adding the World Health Organisation (WHO) estimated at least 2,700 drowning deaths a year, with children under five at the greatest risk. Africa has seen a 3% decline, while South Africa has struggled to deal with the threat. WHO statistics showed at least 1,600 drowning deaths a year in the country, but these figures did not include deaths from flooding disasters, LSA said. 'In South Africa the crisis is worsened by climate change and flooding disasters, such as those in the Eastern Cape in June, and preventable risks such as unsafe farm dams and canals, inadequate water and sanitation infrastructure and traditional baptism ceremonies at rivers and along coastline.'
Mail & Guardian
a day ago
- Mail & Guardian
Poultry sector recovering, prices not expected to increase
South Africa's poultry sector is recovering from a devastating outbreak of bird flu and has capacity to meet local consumer demand. (Madelene Cronje) South Africa's The department of agriculture rolled out mass inoculations earlier this month to protect the industry from highly pathogenic In 2023, millions of birds had to be culled, hampering production and driving up poultry and egg prices. The inoculation campaign kicked off with the vaccination of 200 000 broiler breeders at poultry producer Astral. The birds represent 5% of the company's total breeding stock, the department said. Industry experts have welcomed the inoculation drive. 'We had two cases of HPAI in the country, but both were contained and did not spread with minimum losses in terms of production,' said Izaak Breitenbach, the chief executive of the South African Poultry Association. 'We still have an additional one million birds per week slaughter capacity. We currently slaughter about 21.5 million birds per week.' That number reflects normal production levels, which may rise slightly toward December because sales typically increase in the second half of the year. Breitenbach said the industry also has the capacity to exceed this demand if needed 'The industry can cover an increase in demand of about 10% with local production in the short term and probably more in the long term.' Agriculture economists said the success rate for the inoculations will depend on how well future outbreaks are contained. (Graphic: John McCann/M&G) 'There are great expectations that South Africa's recent efforts to vaccinate poultry against avian flu will lessen the likelihood of another devastating outbreak similar to the one that occurred in 2023. Particularly in light of the seasonal influenza outbreak, which usually starts in April and peaks in September each year,' said Thabile Nkunjana, of the National Agricultural Marketing Council. 'However, the initial vaccination is reportedly for at least 200 000 broilers, which is extremely small compared to the size of the industry as a whole. As a result, there is still a chance of an outbreak related to South African poultry production, as well as a current risk of disruptions in the poultry supply, which frequently results in prices that have a negative impact on consumers The layer side of the poultry industry, which raises chickens specifically for egg production, is still producing at lower levels comparable to those before the 2023 outbreak, Nkunjana noted. 'If an outbreak were to occur, the industry would likely experience the same level of pressure as it did in 2023, and egg prices would probably rise once more,' he said. Experts warned that the cost of bird feed could hamper poultry production. Prices have increased on the back of climate conditions as well as international supply. 'Initially feed costs rose when world prices increased sharply in the aftermath of the pandemic and associated supply chain challenges, challenging weather in some key production regions and Russia's invasion of Ukraine,' said Tracy Davids, the executive director for commodity markets and foresight at the Bureau for Food and Agricultural Policy. 'When world prices came down, South African prices stayed higher due to the summer drought of 2024. So, feed costs have increased much more than meat prices over the past five years, making life difficult for all livestock producers, but particularly poultry that use feed very intensively. It's the biggest cost component in the sector.' With feed prices declining and the partial lifting of the ban on Brazilian chicken imports earlier this month, the prospects for the sector are looking positive, Davids added. The ban was implemented after Brazil also reported disease outbreaks, but was lifted to support South African consumers' food security, alleviate cost pressures, and help stabilise the supply chain, said Nkunjana.
Mail & Guardian
a day ago
- Mail & Guardian
Aid cuts, including by UK, undermine progress on fight against superbugs
Antimicrobial resistance silent pandemic that already claims more than 1.3 million lives every year. File photo A recent global economic model warns that antimicrobial resistance (AMR) may cost the world economy up to This escalating threat coincides with a decline in international support for AMR surveillance. The Low- and middle-income countries, including South Africa, are likely to bear the heaviest burden because of under-resourced health systems, limited surveillance capacity and growing barriers to effective treatments. AMR arises when microorganisms evolve mechanisms to withstand the effects of antibiotics intended to eliminate them. As resistance spreads, infections that were once easily treatable become increasingly difficult, and sometimes impossible, to cure. This silent pandemic is already responsible for more than By 2050, resistant infections could reduce global GDP by up to 3.1% and push millions into poverty as a result of the cost of prolonged illness and ineffective treatment. Health systems, especially in countries already facing a high burden of disease, are at risk of being overwhelmed. The But Experts caution that even partial reductions in funding may accelerate the spread of AMR in high-risk regions. Such cutbacks can delay the detection of resistant pathogens, disrupt surveillance efforts and weaken public health responses. The consequences are clear: more infections, higher mortality rates and mounting pressure on already overstretched health systems. AMR does not respect borders. Resistant bacteria can emerge in one location and spread globally through travel, trade and migration. Inadequate surveillance in one part of the world increases vulnerability everywhere. Many low- and medium-income countries face compounded problems: limited access to diagnostics, overuse or misuse of antibiotics in both clinical and agricultural settings, as well as underinvestment in water, sanitation and hygiene infrastructure. Surveillance programmes supported by international aid help fill these gaps by enabling early detection and informed response. Cutting funding now undermines global preparedness just as AMR risks are accelerating. While AMR is a long-term challenge, the window for effective action is narrowing. Delaying investment now will probably increase the cost and complexity of response in the future. According to recent economic analyses, every dollar spent on AMR containment today could save up to $20 in future health and productivity costs. Continued investment in surveillance, laboratory capacity, workforce training and antimicrobial stewardship is essential for all countries and for global health security. Multilateral partnerships, sustained funding, and equitable access to innovation are critical pillars of any effective AMR strategy. What can be done? Given the recent decline in global funding, it is essential to explore alternative strategies to sustain and strengthen AMR efforts. Reinforce multilateral funding: Donor countries should explore shared funding mechanisms to sustain critical AMR programmes beyond bilateral commitments. Strengthen regional cooperation: Regional AMR surveillance networks can improve resilience and facilitate data-sharing, even in the face of international funding cuts. Mobilise domestic resources: Prioritise public health investment in laboratory systems, data infrastructure, and training to reduce reliance on fluctuating aid flows. Promote responsible antimicrobial use: Stewardship programmes in human and veterinary medicine are essential to slow the development of resistance. Invest in research and equitable access: Support for the development and fair distribution of new antibiotics, vaccines, and diagnostics must remain a global priority. AMR is one of the most urgent and complex public health issues of our time. Progress made in the past decade, through global collaboration, investment and capacity-building now stands at risk. At the very moment when stronger action is needed, international funding is contracting. The decisions made now will shape the trajectory of AMR for decades. Reducing support is not just a financial recalibration; it is a choice that may have irreversible consequences for millions of people worldwide. The global community must act decisively to protect hard-won gains, support countries most at risk and uphold the shared responsibility of safeguarding the effectiveness of life-saving medicines. Dr Jose L Balcazar is a senior microbiologist at the Catalan Institute for Water Research (ICRA-CERCA), Spain.
